Precision Medicine Market

Precision Medicine Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

250

Base Year:

2024

Dec - 2024

Format:

Report Code:

VMR-3925

Segments Covered

By Type Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral drugs, Other Therapeutic Products
By Indication Oncology, Rare Diseases, Infectious diseases, Hematological disorders, Other indications
By End User Hospitals and Clinics, Home care settings
By Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Standard License

$ 4099 USD

Multi User License

$ 5250 USD

Enterprise License

$ 6400 USD

Snapshot

Base Year:	2024
Forecast Years:	2025 - 2035
Historical Years:	2019 - 2023
Revenue 2024:	USD 31.94 Billion
Revenue 2035:	USD 103.73 Billion
Revenue CAGR (2025 - 2035):	11.3%
Fastest Growing Region (2025 - 2035)	Asia Pacific
Largest Region (2024):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Precision Medicine Market - Segment Analysis
1. Overview
2. Global Precision Medicine Market, 2016 - 2028 (USD Million)
3. Global Precision Medicine Market - by Type
  1. By Inhibitor Drugs
  2. By Monoclonal Antibodies
  3. By Cell & Gene Therapy
  4. By Antiviral & Anti-retroviral drugs
  5. By Other Therapeutic Products
4. Global Precision Medicine Market - by Indication
  1. By Oncology
  2. By Rare Diseases
  3. By Infectious diseases
  4. By Hematological disorders
  5. By Other indications
5. Global Precision Medicine Market - by End User
  1. By Hospitals and Clinics
  2. By Home care settings
6. Global Precision Medicine Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Precision Medicine Market - Segment Analysis
1. Overview
2. North America Precision Medicine Market, 2016 - 2028 (USD Million)
3. North America Precision Medicine Market, by Type
  1. By Inhibitor Drugs
  2. By Monoclonal Antibodies
  3. By Cell & Gene Therapy
  4. By Antiviral & Anti-retroviral drugs
  5. By Other Therapeutic Products
4. North America Precision Medicine Market, by Indication
  1. By Oncology
  2. By Rare Diseases
  3. By Infectious diseases
  4. By Hematological disorders
  5. By Other indications
5. North America Precision Medicine Market, by End User
  1. By Hospitals and Clinics
  2. By Home care settings
6. North America Precision Medicine Market, by Country
  1. U.S.
    1. U.S. Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. U.S. Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. U.S. Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  2. Canada
    1. Canada Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Canada Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Canada Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  3. Mexico
    1. Mexico Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Mexico Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Mexico Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
Europe Precision Medicine Market - Segment Analysis
1. Overview
2. Europe Precision Medicine Market, 2016 - 2028 (USD Million)
3. Europe Precision Medicine Market, by Type
  1. By Inhibitor Drugs
  2. By Monoclonal Antibodies
  3. By Cell & Gene Therapy
  4. By Antiviral & Anti-retroviral drugs
  5. By Other Therapeutic Products
4. Europe Precision Medicine Market, by Indication
  1. By Oncology
  2. By Rare Diseases
  3. By Infectious diseases
  4. By Hematological disorders
  5. By Other indications
5. Europe Precision Medicine Market, by End User
  1. By Hospitals and Clinics
  2. By Home care settings
6. Europe Precision Medicine Market, by Country
  1. Germany
    1. Germany Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Germany Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Germany Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  2. UK
    1. UK Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. UK Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. UK Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  3. France
    1. France Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. France Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. France Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  4. Spain
    1. Spain Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Spain Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Spain Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  5. Italy
    1. Italy Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Italy Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Italy Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  6. BENELUX
    1. BENELUX Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. BENELUX Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. BENELUX Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  7. Rest of Europe
    1. Rest Of Europe Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Rest Of Europe Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Rest Of Europe Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
Asia Pacific Precision Medicine Market - Segment Analysis
1. Overview
2. Asia Pacific Precision Medicine Market, 2016 - 2028 (USD Million)
3. Asia Pacific Precision Medicine Market, by Type
  1. By Inhibitor Drugs
  2. By Monoclonal Antibodies
  3. By Cell & Gene Therapy
  4. By Antiviral & Anti-retroviral drugs
  5. By Other Therapeutic Products
4. Asia Pacific Precision Medicine Market, by Indication
  1. By Oncology
  2. By Rare Diseases
  3. By Infectious diseases
  4. By Hematological disorders
  5. By Other indications
5. Asia Pacific Precision Medicine Market, by End User
  1. By Hospitals and Clinics
  2. By Home care settings
6. Asia Pacific Precision Medicine Market, by Country
  1. China
    1. China Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. China Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. China Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  2. Japan
    1. Japan Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Japan Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Japan Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  3. India
    1. India Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. India Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. India Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  4. South Korea
    1. South Korea Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. South Korea Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. South Korea Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  5. South East Asia
    1. South East Asia Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. South East Asia Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. South East Asia Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Rest of Asia Pacific Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Rest of Asia Pacific Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
Latin America Precision Medicine Market - Segment Analysis
1. Overview
2. Latin America Precision Medicine Market, 2016 - 2028 (USD Million)
3. Latin America Precision Medicine Market, by Type
  1. By Inhibitor Drugs
  2. By Monoclonal Antibodies
  3. By Cell & Gene Therapy
  4. By Antiviral & Anti-retroviral drugs
  5. By Other Therapeutic Products
4. Latin America Precision Medicine Market, by Indication
  1. By Oncology
  2. By Rare Diseases
  3. By Infectious diseases
  4. By Hematological disorders
  5. By Other indications
5. Latin America Precision Medicine Market, by End User
  1. By Hospitals and Clinics
  2. By Home care settings
6. Latin America Precision Medicine Market, by Country
  1. Brazil
    1. Brazil Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Brazil Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Brazil Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  2. Argentina
    1. Argentina Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Argentina Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Argentina Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  3. Rest of Latin America
    1. Rest of Latin America Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Rest of Latin America Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Rest of Latin America Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
Middle East & Africa Precision Medicine Market - Segment Analysis
1. Overview
2. Middle East & Africa Precision Medicine Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Precision Medicine Market, by Type
  1. By Inhibitor Drugs
  2. By Monoclonal Antibodies
  3. By Cell & Gene Therapy
  4. By Antiviral & Anti-retroviral drugs
  5. By Other Therapeutic Products
4. Middle East & Africa Precision Medicine Market, by Indication
  1. By Oncology
  2. By Rare Diseases
  3. By Infectious diseases
  4. By Hematological disorders
  5. By Other indications
5. Middle East & Africa Precision Medicine Market, by End User
  1. By Hospitals and Clinics
  2. By Home care settings
6. Middle East & Africa Precision Medicine Market, by Country
  1. GCC Countries
    1. GCC Countries Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. GCC Countries Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. GCC Countries Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  2. South Africa
    1. South Africa Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. South Africa Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. South Africa Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Precision Medicine Market, By Type
      1. By Inhibitor Drugs
      2. By Monoclonal Antibodies
      3. By Cell & Gene Therapy
      4. By Antiviral & Anti-retroviral drugs
      5. By Other Therapeutic Products
    2. Rest of Middle East & Africa Precision Medicine Market, By Indication
      1. By Oncology
      2. By Rare Diseases
      3. By Infectious diseases
      4. By Hematological disorders
      5. By Other indications
    3. Rest of Middle East & Africa Precision Medicine Market, By End User
      1. By Hospitals and Clinics
      2. By Home care settings
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Pfizer Inc.
2. Hoffmann-La Roche Ltd.
3. Novartis AG
4. Bristol Myers Squibb
5. AstraZeneca
6. Gilead Sciences Inc.
7. Eli Lilly and Company
8. GlaxoSmithKline plc
9. Sanofi
10. Johnson & Johnson
11. Merck KGaA
12. Amgen Inc.
13. AbbVie Inc.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Precision Medicine in terms of revenue?

The global Precision Medicine valued at USD 31.94 Billion in 2024 and is expected to reach USD 103.73 Billion in 2035 growing at a CAGR of 11.3%.

Which are the prominent players in the market?

The prominent players in the market are Pfizer Inc., Hoffmann-La Roche Ltd., Novartis AG, Bristol Myers Squibb, AstraZeneca, Gilead Sciences Inc., Eli Lilly and Company, GlaxoSmithKline plc , Sanofi, Johnson & Johnson, Merck KGaA, Amgen Inc., AbbVie Inc..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 11.3% between 2025 and 2035.

What are the driving factors fueling the growth of the market.

The driving factors of the Precision Medicine include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Precision Medicine in 2024.

Precision Medicine Market

Precision Medicine Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Precision Medicine in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Precision Medicine Market

Precision Medicine Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Precision Medicine in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Precision Medicine Market

Vantage Point Interactive Dashboard